We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Grocery Outlet
GO
$909M
| $4.08M | 0.05% |
133,203
+55,004
| +70% | +$1.61M |
|
327
Vita Coco
COCO
$3.82B
| $4.03M | 0.05% |
+150,002
| New | +$3.65M |
|
328
Viridian Therapeutics
VRDN
$2.09B
| $4M | 0.05% |
168,060
+48,611
| +41% | +$1.25M |
|
329
Crown Holdings
CCK
$12.8B
| $3.98M | 0.05% |
+45,768
| New | +$3.77M |
|
330
Endava
DAVA
$158M
| $3.94M | 0.05% |
76,060
| – | – |
|
|
MYD
331
DELISTED
BlackRock MuniYield Fund
MYD
| $3.94M | 0.05% |
377,284
-273,903
| -42% | -$2.85M |
|
332
Ralph Lauren
RL
$22.6B
| $3.92M | 0.05% |
+31,822
| New | +$3.67M |
|
|
ONC
333
BeOne Medicines Ltd
ONC
$32.8B
| $3.89M | 0.05% |
21,816
-64,729
| -75% | -$14.9M |
|
|
SWTX
334
DELISTED
SpringWorks Therapeutics
SWTX
| $3.85M | 0.05% |
147,000
-1,300,389
| -90% | -$34.2M |
|
335
Floor & Decor
FND
$6.13B
| $3.82M | 0.05% |
+36,749
| New | +$3.51M |
|
|
MVF
336
DELISTED
BlackRock MuniVest Fund
MVF
| $3.8M | 0.05% |
564,344
-429,081
| -43% | -$2.89M |
|
337
GoodRx Holdings
GDRX
$1.04B
| $3.73M | 0.04% |
675,728
+61,278
| +10% | +$330K |
|
338
Scholar Rock
SRRK
$5.67B
| $3.73M | 0.04% |
+494,467
| New | +$3.73M |
|
339
Qiagen
QGEN
$8.54B
| $3.71M | 0.04% |
77,684
+55,744
| +254% | +$2.69M |
|
340
Donaldson
DCI
$10.9B
| $3.71M | 0.04% |
59,310
-73,053
| -55% | -$4.57M |
|
|
ODP
341
DELISTED
ODP
ODP
| $3.67M | 0.04% |
78,440
+47,003
| +150% | +$2.02M |
|
|
ZLS
342
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $3.67M | 0.04% |
354,215
| – | – |
|
|
PEGR
343
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $3.63M | 0.04% |
350,000
| – | – |
|
344
Boot Barn
BOOT
$4.51B
| $3.61M | 0.04% |
42,613
+13,925
| +49% | +$1.02M |
|
345
TG Therapeutics
TGTX
$7.96B
| $3.51M | 0.04% |
+141,500
| New | +$3.65M |
|
346
Zumiez
ZUMZ
$332M
| $3.51M | 0.04% |
210,843
+10,766
| +5% | +$180K |
|
347
Treace Medical Concepts
TMCI
$280M
| $3.5M | 0.04% |
+137,011
| New | +$3.54M |
|
|
FNA
348
DELISTED
Paragon 28, Inc.
FNA
| $3.44M | 0.04% |
193,981
+164,128
| +550% | +$2.95M |
|
349
Vor Biopharma
VOR
$1.15B
| $3.43M | 0.04% |
55,556
| – | – |
|
|
TRTL
350
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $3.43M | 0.04% |
331,500
| – | – |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.